A Randomised, double blind, placebo controlled, three-way cross over study to evaluate the attention and cognitive function after single dose administration of Eszopiclone and Ramelteon using computerized stroop color word test in healthy human participants

izams Institute of Medical Sciences0 个研究点目标入组 15 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Participants of either gender between 18-45 years of age and BMI of 18.5 to < 25 kg/m2.
•2. Participants willing to sign informed consent.
•3. Participants with normal physical, clinical examination and lab investigations.
•4. Able to perform the test procedures, as per the protocol.
•5. Participants with normal to corrected vision.
•6. Able to read English words

•1. H/o of psychiatric illiness, insomnia, use of any psychiatric medication.
•2. H/o of drug dependence or any severe co-morbid medical conditions.
•3. H/o of serious adverse reactions or hypersensitivity to any drug.
•4. Abnormality in lab investigations like complete blood picture, complete urine examination, liver function tests or renal function tests.
•5. Participating in any drug trials/ research projects over the past 3 months.
•6. Alcohol consumption 24 hrs before study day.
•7. Tea / Coffee consumption or smoking 12 hrs before the study day.
•8. Pregnant/breast feeding/ child bearing potential participants

发起方

izams Institute of Medical Sciences